Skip to content
Samsung Biologics
-
Samsung Biologics expands US presence with acquisition of Human Genome Sciences Facility in Maryland
This deal gives Samsung Biologics its first manufacturing site in the US and reinforces its long-term commitment to serving the North American biopharmaceutical market.